Interview guides · Boston Children's Hospital

Boston Children's Hospital Data Scientist Interview Questions & Guide 2026

Diagnose a metric move for Boston Children's Hospital data scientist prep: split by segment, rule out a logging change, separate mix shift from behaviour.

The 60-second brief

A Data Scientist at Boston Children's Hospital occupies a unique and highly impactful position at the intersection of pediatric healthcare, clinical research, and advanced data engineering. Unlike traditional tech environments where data science drives advertising or click-through rates, your work here directly contributes to improving patient outcomes, optimizing clinical workflows, and advancing medical research. You will collaborate with world-class clinicians, researchers, and healthcare administrators to translate complex medical data into actionable insights that can save lives.

Product-sense cases reward reasoning from a mechanism to a testable prediction. Reciting every metric you can name reads as pattern matching; naming the single quantity that would move if your explanation were true reads as thinking.

Focus areas

Reconstruct drug exposure intervals from dispensing records
Minimise protected health information in every extract
Risk-adjust outcomes before comparing providers or panels

Overview

The role is highly multidisciplinary and embedded within specific clinical centers, research labs, or administrative departments. You will tackle diverse challenges, ranging from analyzing high-dimensional genomic sequences and electronic health records (EHR) to building predictive models for patient deterioration or optimizing resource allocation across the hospital. Your ability to extract signals from noisy, unstructured clinical data and communicate those findings to non-technical stakeholders is what makes this role both intellectually challenging and deeply rewarding.

By joining Boston Children's Hospital, you become part of an institution dedicated to solving some of the most complex pediatric health challenges in the world. The models you build and the analyses you perform will directly influence clinical decision-making, shape institutional policies, and contribute to pioneering medical publications. It is a role where technical excellence meets profound human impact.

The Boston Children's Hospital interview process

Boston Children's Hospital candidates report 4 rounds · ≈ 3-5 weeks. The stages below are what candidates describe, not a published process.

HR Phone Screen

Whoever runs this call is usually not a practitioner. They take notes, and a hiring manager skims those notes later, so the real question is whether your work survives being written down by someone outside the field. Test every project sentence against that: could a non-specialist repeat it correctly without knowing what a propensity score is? Carry a plain-language version of each project and one reason you want this particular role that you could not copy onto another application. Vagueness at this stage reads as inexperience, even when the underlying work was genuinely deep.

What to demonstrate

Whether a non-specialist can restate your projects accurately, since their paraphrase is what reaches the hiring manager
Whether your reason for wanting the role points at the work itself rather than the company's reputation
Whether your language signals the level being screened for: what you decided yourself versus what you were handed

How to prepare

Write a two-sentence, jargon-free version of each major project: the question nobody could answer, and the decision your work changed. Read it to someone outside data and have them repeat it back
Point your 'why this role' answer at something concrete in the job description or the product surface you would be working on, and keep it to two sentences
Have two questions ready about measurement: which metric the team is held to, and who acts on an analysis once it lands

Hiring Manager Conversation

Expect a live problem with pieces of it missing, closer to a conversation than an exam. A metric moved, or somebody wants to know whether a change worked, and you are asked how you would find out. The manager is watching the first ninety seconds, specifically whether you establish what decision hangs on the answer before you start proposing methods. Candidates who open with a technique get steered back. Once the decision is clear, describe what the data would look like if the story were true, and say what you would accept as evidence that it is not.

What to demonstrate

Whether you fix the decision the analysis serves before choosing an approach
How you continue when you are told the data you just asked for does not exist
Whether you state what would change your mind, not only what would confirm the hypothesis you started with
How you size an effect before you have measured it

How to prepare

Take a metric you know well and practise explaining in under two minutes the four things that could have moved it and how you would separate them
Pick a recent launch or experiment and write the single number you would ask for first, plus what you would conclude if it came back flat
Practise being interrupted: have someone remove a data source halfway through your answer and carry on without restarting

Presentation Round

An added round often puts you in front of someone outside the core hiring team: a partner engineer, a product owner, a domain expert, sometimes a more senior manager. The question they are really asking is not whether you can do the work but whether they would trust a number that came from you. That changes what a good answer looks like. Lead with what the decision cost and what it changed, keep the method available but not central, and be plain about the limits of your evidence. Overstating a result is the fastest way to lose this round.

What to demonstrate

Whether you can explain a technical choice to someone who will never read your code, without either flattening it into nothing or hiding inside jargon
Honesty about evidence strength: what the analysis establishes, what it only suggests, and what it cannot say at all
How you take disagreement, specifically whether you update on a good objection, hold your position with reasons, or fold on contact

How to prepare

Write the two-sentence version of your most technical project for a non-specialist, then check that neither sentence needs a method name to make sense.
For one result you are proud of, write the strongest objection someone could raise and a response that concedes the part of it that is correct.
Prepare one decision that turned out to be wrong: how you found out, what it cost, and what you changed afterwards. A senior cross-functional interviewer asks for this more often than a technical one does.

Stakeholder Conversations

An extra round usually exists because something is still open after the standard loop: a skill the earlier interviews did not sample, a level decision, or two interviewers who disagreed. It is rarely a rerun of what you already did well. Ask the recruiter who you are meeting, what function they sit in, and how long the session runs. That is an ordinary scheduling question, and the answer changes what you should prepare. What separates a strong candidate here is treating the round as a fresh evaluation with its own bar, rather than assuming earlier performance carries you through or sinks you.

What to demonstrate

Whether you can answer well on ground the earlier rounds did not cover, without leaning on what you already said to someone else
Consistency of the facts in your stories: the same sample size, timeframe, team size and scope of your own role as in earlier conversations
How you handle an unfamiliar format live, including whether you ask what kind of answer is wanted before producing one

How to prepare

Ask the recruiter for the interviewer's function, the length, and whether to expect a coding surface, a discussion, or a presentation. Preparing for a 30 minute conversation with a partner team is not the same work as preparing for a 60 minute technical block.
Write out what each earlier round actually covered, then list the two or three areas nobody probed. That gap is the most likely subject of the extra round.
Re-read the numbers in the project stories you have already told, so a second telling does not quietly contradict the first.

Where candidates lose points

Treating clinical measurements as missing at random

A lab result, a vital sign, or a screening exists because someone ordered it, and ordering tracks suspicion of disease, visit frequency, and site workflow. Imputing the mean or dropping incomplete rows biases the population estimate and can flip the sign of an association, because the untested are systematically healthier or systematically disengaged. The presence indicator is often more predictive than the value, which is a warning sign rather than a feature win: a model that learns test ordering will not transfer to a site with different protocols.

Immortal time in adherence, treatment, and enrolment definitions

Classifying members as adherent, treated, or programme-enrolled requires them to survive and stay covered long enough to accumulate the defining events. That guaranteed event-free interval is assigned to the exposed group, so the exposure looks protective for reasons that have nothing to do with the treatment. Adherence studies are the classic case: measuring 12-month proportion of days covered and then comparing mortality builds survival into the exposure definition. Use time-varying exposure or a landmark analysis with the classification window excluded from follow-up.

Averaging per-user rates to produce a population rate

Decide which quantity you want: the mean of per-user ratios and the ratio of summed numerator to summed denominator are different estimands, and heavy users dominate one but not the other. For a ratio metric, aggregate numerator and denominator separately and use the delta method for its variance.

Reporting a mean for a heavy-tailed metric without saying what it hides

For spend, session length or items per order, a small fraction of units carries most of the total, so the mean has a wide standard error and one account can move it. Fix the handling before you see the result: cap or winsorise at a pre-declared percentile, and report the median or the share above a threshold next to the mean. Capping changes the estimand, so say which question the capped number answers, and check how much of any difference comes from the top 0.1 percent of units.

Questions & practice

Can you explain the difference between a random forest and a gradient boosted machine, and when you would use one over the other?

Medium · machine learning and modelling

Approach

Check what information would not exist at prediction time, and exclude it.
Say how the offline result would be validated online before it is trusted.
Frame the prediction: the label, the moment of prediction, and the action it triggers.

Follow-up

Where could label leakage enter this setup?
How would you choose the decision threshold, and who owns that choice?

How would you present a highly technical machine learning model to a group of physicians who have no background in computer science?

Medium · machine learning and modelling

Approach

Check what information would not exist at prediction time, and exclude it.
Pick an evaluation metric that matches the cost of each error type, not a default.
Frame the prediction: the label, the moment of prediction, and the action it triggers.

Follow-up

Where could label leakage enter this setup?
What would you monitor after launch to know the model is still valid?

Bootstrap a confidence interval for a ratio-of-sums PMPM

Medium · bootstrap · ratio estimator · resampling unit

You have one row per member for a fully run-out incurred year: member_id, member_months, allowed_amount. Report allowed PMPM, defined as sum(allowed_amount) divided by sum(member_months), with a 95 percent confidence interval from a bootstrap you write yourself. No library resampler. Resample members with replacement, recompute the ratio on each of 2,000 replicates, take a percentile interval, and seed the generator so the result reproduces. In two sentences, state why resampling claim lines instead of members would be wrong.

Approach

Name the estimator precisely: PMPM is a ratio of sums, not the mean of per-member ratios. The two differ whenever exposure correlates with spend, and it does, because members who churn out mid-year are systematically different from members covered all twelve months.
Resample the unit of independence, which is the member, and recompute numerator and denominator together on the same draw. Recomputing only the numerator against a fixed denominator understates variance and is a common slip.
Pull member_months and allowed_amount into numpy arrays once, then draw indices with rng.integers(0, n, size=n) per replicate. Index draws over arrays run one to two orders of magnitude faster than DataFrame.sample, which is the difference between 2,000 replicates and 200.
Take the 2.5th and 97.5th percentiles of the replicate ratios. Expect an interval that is asymmetric around the point estimate, because healthcare spend is right skewed. That asymmetry is the method working, not a bug to centre away.
Answer the line-resampling question concretely: the many lines of one high-cost member are not independent draws, so line resampling shrinks the interval toward zero width, and member_months has no line-level analogue, so the denominator becomes undefined.

Worked solution (25 min)

Compute the point estimate as allowed.sum() / months.sum() on the full sample.
Extract both columns to float numpy arrays and create rng = np.random.default_rng(seed).
Loop 2,000 times: idx = rng.integers(0, n, n); ratio = allowed[idx].sum() / months[idx].sum(); store it.
Take np.percentile(replicates, [2.5, 97.5]) and report the point estimate with that interval and the seed.

Expected result: A point estimate plus a 95 percent percentile interval that is wider on the upper side than the lower. With tens of thousands of members and a typical commercial cost distribution the relative half-width lands on the order of a few percent; an interval a small fraction of a percent wide is the signature of having resampled rows rather than members.

Verify it yourself

Re-running with the same seed reproduces both bounds exactly.
Raising replicates from 2,000 to 8,000 moves each bound by less than its third significant figure.
The mean of the replicate ratios sits close to the point estimate; a large gap indicates a bug in the resampler rather than skew.
Replicate denominators cluster tightly around the observed total member-months, which confirms the draw size is n rather than a fixed constant.

Follow-up

Half a percent of members have a transplant or a long NICU stay. Does a percentile interval still have nominal coverage, and what would you do about the tail?
The question changes to comparing PMPM across provider panels. What becomes the resampling unit and why?
How would you use the same replicates to test whether this year's PMPM differs from last year's, given the same members appear in both?

Describe your experience working with SQL and relational databases to extract large-scale datasets.

Medium · sql and data manipulation

Approach

Check whether any join is one-to-many before aggregating, or the sums inflate.
Compute rates by summing numerator and denominator separately, never by averaging rates.
State the window function and its partition and ordering out loud before writing it.

Follow-up

How does the query change if the join becomes one-to-many?
How would you verify this result without re-running the same query?

Reconstruct drug coverage intervals and compute proportion of days covered

Hard · gaps and islands · window functions · adherence

pharmacy_claim holds fill_id, member_id, ndc_code, therapeutic_class_code, fill_date, days_supply, reversal_flag and reversed_fill_id. Early refills overlap, so days_supply must be laid end to end: each fill's coverage starts at the later of its fill_date and the previous interval's end. Both rows of a reversed pair are excluded. For one therapeutic_class_code over 2025-01-01 to 2025-06-30, return per member the proportion of days covered, defined as covered days divided by days from first fill_date to window end, plus the share of members at or above 0.80. Require at least two fills and 91 days of follow-up.

Approach

Clean the fills first. Drop rows with reversal_flag TRUE and also the fills they point at through reversed_fill_id. Dropping only the reversal row leaves an original fill counted as exposure that never reached the member. Use NOT EXISTS for that second step, since reversed_fill_id is nullable and NOT IN would return nothing.
Shift, never stack. The shifted end is covered_end_i = GREATEST(fill_date_i, covered_end_{i-1}) + days_supply_i, which looks recursive but has a closed form: with cum_i the running sum of days_supply through fill i, covered_end_i = cum_i + MAX over j <= i of (fill_date_j - cum_{j-1}). That is SUM(days_supply) OVER (ORDER BY fill_date ROWS UNBOUNDED PRECEDING) plus a running MAX of an anchor column, so it is two window functions and no recursive CTE.
Derive covered_start_i as GREATEST(fill_date_i, LAG(covered_end)). The intervals are disjoint by construction, so covered days is a plain sum of lengths and never needs a distinct day grid.
Clip intervals to the window end before summing, and decide explicitly whether to clip at disenrollment as well. Supply that runs past the window must not inflate the numerator.
Use the denominator the spec names, first fill_date to window end, and hold it constant across classes. A fixed-window denominator yields a different and usually lower number, and mixing the two across classes makes the comparison meaningless.
Apply the inclusion rules at member level after the intervals are built, then compute the share at or above 0.80 with the qualifying member count beside it.

Worked solution (40 min)

Filter to the therapeutic_class_code and window, then remove reversal rows and their originals with NOT EXISTS.
Per member ordered by fill_date, compute cum_supply and anchor = fill_date - (cum_supply - days_supply), then covered_end = cum_supply + MAX(anchor) OVER (ORDER BY fill_date ROWS UNBOUNDED PRECEDING).
Compute covered_start = GREATEST(fill_date, LAG(covered_end) OVER (ORDER BY fill_date)), clip both ends to the window, and drop intervals that collapse.
Sum interval lengths as covered_days, compute follow_up_days from first fill_date to window end, and divide.
Apply the two-fill and 91-day rules, then aggregate the share at or above 0.80.

Expected result: One row per qualifying member with covered_days, follow_up_days and pdc in [0, 1], plus a summary row with qualifying members and the share at or above 0.80. A member with 30-day fills on 2025-01-01, 2025-01-20 and 2025-04-01 is covered 2025-01-01 to 2025-03-01 and 2025-04-01 to 2025-04-30, giving 60 + 30 = 90 covered days over 181 follow-up days and a PDC of 0.497.

Verify it yourself

No pdc exceeds 1.0 before any clipping. A value above 1 proves supplies were stacked instead of shifted.
On a twenty-member sample, the summed interval lengths equal the distinct covered day count from a slow day-grid version.
A member with one fill is excluded by the two-fill rule rather than appearing with a PDC of 1.0.
Re-running with reversals left in raises covered days for exactly the members who have a reversed_fill_id, and for no one else.

Follow-up

A member is hospitalised for twelve days mid-window, when the facility supplies medication. Should those days count as covered, and what do published adherence measures do about them?
Someone wants to classify adherence over twelve months and then compare mortality from month zero. What is wrong with that design and what fixes it?
Two different ndc_codes in the same therapeutic class overlap. Is that stacking or switching, and how does your interval logic treat each case?

Walk us through a complex data science project you led from inception to deployment.

Medium · product sense and metrics

Approach

Restate the decision this analysis has to support, and who acts on the answer.
Fix the population and the time window before naming any metric.
Name one primary metric, then the guardrail that stops it being gamed.

Follow-up

How would you detect that the metric is being gamed rather than genuinely improving?
What would you do if the primary metric and the guardrail moved in opposite directions?

What programming languages are you most comfortable with for data analysis, and why?

Medium

Approach

State your assumptions explicitly before working the problem.
Say what you would check first and why it is the highest-information step.
Work from the decision backwards to the evidence you would need.

Follow-up

What assumption would you test first?
How would you know your answer was wrong?

How do you ensure your predictive models do not inherit or amplify biases present in historical clinical data?

Medium

Approach

Say what you would check first and why it is the highest-information step.
Work from the decision backwards to the evidence you would need.
State your assumptions explicitly before working the problem.

Follow-up

What assumption would you test first?
How would you know your answer was wrong?

Evaluate a book-wide benefit change with no untreated members

Hard · difference-in-differences · synthetic control · parallel trends · seasonality confounding

On 1 January a therapeutic class moves from formulary tier 2 to tier 3, raising member cost share, for the entire commercial group book at once. No untreated subset of that book exists. You have 36 months of pharmacy_claim and member_enrollment covering that book plus the Medicare Advantage and Medicaid managed books, which are unaffected. Outcomes are class fills per 1,000 member-months and the share of members with PDC at or above 0.80. Give the design, the identifying assumption, and how you would test it.

Approach

Rule out the single-series interrupted time series first and say why. The change lands on 1 January, which is also when deductibles reset, benefit designs change, and members switch plans, so a level shift at the new year is confounded with the entire annual benefit cycle. Any design that cannot separate those two is not usable here.
Build an event-study difference-in-differences with the unaffected product books as controls, estimating month-by-month coefficients relative to December. The lead coefficients are the test of the identifying assumption, not decoration: they should be indistinguishable from zero, and you should say in advance what magnitude of lead violation would make you abandon the design.
State what the control books are doing for you and what they are not. They experience the same January reset, which is precisely why they are useful, but they differ in population age, cost-sharing structure, and eligibility churn, so parallel counterfactual trends is a real assumption and residual confounding should be named rather than waved at.
Add a synthetic control as the robustness check: construct a weighted combination of donor series (other product books crossed with other therapeutic classes) that tracks the treated series through the pre-period, and do inference by permutation, assigning the intervention to each donor and comparing post-to-pre RMSPE ratios. Require that the treated pre-period sits inside the convex hull of the donors, and abandon the approach if pre-period fit is poor.
Fix the population before estimating anything. If the tier move pushes members out of the book, the post-period population differs from the pre-period one, so restrict to members continuously enrolled across the window with a stated allowable gap, and report sensitivity to that gap. Note that pharmacy claims adjudicate in days, so unlike a medical-cost series this outcome is essentially complete within weeks.

Worked solution (45 min)

Build a monthly panel of fills per 1,000 member-months and PDC share by product book, restricted to members continuously enrolled across the window with a 45-day allowable gap.
Plot the treated and control series for 24 pre-period months and inspect visually before fitting anything.
Estimate an event-study DiD with month-relative-to-January coefficients, product fixed effects, and calendar-month fixed effects, clustering standard errors at the product-book level or higher.
Run the placebo: re-estimate as if the change happened on the prior 1 January, which isolates the annual reset from the tier move.
Fit a synthetic control on donor product-class series, check pre-period RMSPE, and run the permutation inference across donors.

Expected result: An event-study difference-in-differences of the affected commercial book against unaffected product books on continuously enrolled members, with a synthetic control and permutation inference as the robustness check. The identifying assumption is parallel counterfactual trends, tested by null lead coefficients and by a prior-January placebo that separates the tier change from the deductible reset.

Verify it yourself

Lead coefficients in the event study should be within noise of zero across the pre-period.
The prior-January placebo should return an effect near zero; if it does not, the January reset is contaminating the estimate.
Synthetic control pre-period RMSPE should be small, and the treated unit's post-to-pre RMSPE ratio should be extreme relative to the donor distribution.
The estimate should be stable when the continuous-enrolment gap allowance moves from 0 to 45 days.

Follow-up

The lead coefficients are not flat: the treated book was already drifting down for six months. What do you do without abandoning the question?
Therapeutic substitution is expected. How do you tell a true reduction in therapy from members moving to a cheaper drug in the same class?
How would you report the result so a clinical committee can act on it, given that fills per 1,000 member-months is not an outcome anyone treats?

Glycemic control share jumped when a feed connected

Medium · informative missingness · unit mismatch · metric specification

The share of members with a controlled glycemic result moved from 0.62 to 0.81 the month a second result feed was connected. lab_result carries result_id, order_id, patient_id, encounter_id, loinc_code, analyte_name, value_numeric, units, reference_low, reference_high, abnormal_flag, result_status and supersedes_result_id. The metric is members whose latest result in the year is below the control threshold, divided by members with any result in the year. Decide whether control actually improved, and specify the metric so results from both feeds can be pooled.

Approach

Split numerator and denominator. The denominator is members with any result, so a feed that tests more people changes the metric without changing anyone's health. Count denominator members before and after and see how much of the 19 point move is denominator growth.
Recompute on a fixed cohort: members who had a qualifying result in both the before and after periods. If the share is flat on the fixed cohort, the movement is who got tested, not what their results were.
Deduplicate to the latest non-cancelled row per (order_id, loinc_code), respecting supersedes_result_id, because a corrected result arrives as a new row and counting both gives one person two values.
Audit units and loinc_code mix by feed. Two unit conventions coexist for this analyte, percent and mmol/mol, related by mmol/mol equal to 10.929 times (percent minus 2.15), so 7.0 percent is 53 mmol/mol. Comparing mmol/mol values to a percent threshold would classify them all as uncontrolled and depress the share, so a rise cannot be explained by that mismatch, which rules it out rather than in.
State plainly that the tested population is not the covered population. Testing is ordered when someone suspects a problem or when a site runs standing orders, so the mean among tested members is not the population mean and cannot be made into one by imputation.
Respecify: numerator and denominator both restricted to members with a stated continuous-enrolment requirement, one deduplication rule, one unit after conversion, one threshold, and a separately reported testing rate so the denominator's movement is visible.

Follow-up

Someone proposes imputing the mean result for untested members. What happens to the estimate and why?
A model you are building gains AUC from a feature that marks whether the test exists. Why is that a warning rather than a win?
How would you report this metric so a clinical committee can see improvement separately from coverage of testing?

Suggested practice checklist

Instead of guessing where the week should go, day one measures it under a fixed rubric and allocates the remaining hours in proportion to the gaps. The method is deliberately rigid: the allocation is written down before any studying starts and is not renegotiated when a topic turns out to be unpleasant.

Day 1 — Diagnostic, scored before you study anything

Sit a 100-minute timed diagnostic in four blocks: 30 minutes of SQL across three prompts, 25 minutes of short-answer statistics, 25 minutes on one modelling or case prompt, and 20 minutes delivering one behavioural story aloud.
Score each block from 0 to 3 on a fixed rubric where 3 is correct and fluent, 2 is correct but slow or prompted, 1 is partially correct, and 0 is stuck, grading the output rather than how the attempt felt.
Allocate the hours for days two to five roughly in proportion to 3 minus the score in each block, write the allocation down, and commit to not revising it midweek.

Deliverable: A scored rubric and a fixed hour allocation for the rest of the week.

Day 2 — Largest gap: find the boundary rather than the subject

Break the weakest area into five named sub-skills (for query work: grain control, window frames, date arithmetic, set logic with NULLs, and reading a query plan) and rate each one, so the rest of the week targets a sub-skill instead of a subject.
Solve three problems chosen to sit just above where the rating drops off, and for each write the first move you failed to make.
Re-solve one of them from memory four hours later, on paper, with nothing open.

Deliverable: A five-item sub-skill map with the two blocking sub-skills circled.

Day 3 — Largest gap: drill the blocking sub-skill

Do eight short repetitions of the same shape rather than eight different problems, so what you practise is the pattern and not the puzzle.
Write the rule you now hold in one sentence, then test it against a case built to break it: a ranking function over a column with ties, or a two-sample test on observations that are obviously dependent.
Have someone else read your one-sentence rule and find the precondition you left out.

Deliverable: One rule statement with its preconditions attached and one counterexample that would have caught the incomplete version.

Day 4 — Second gap, plus maintenance on your strongest area

Run the same sub-skill map and boundary protocol on the second-largest gap, compressed into half the day.
Spend 25 timed minutes on your strongest area to stop it decaying, choosing the hardest problem you can still finish rather than an easy warm-up.
Compare how the two areas fail: whether you lose time on recall, on setup, or on arithmetic, because the fix differs for each.

Deliverable: A second sub-skill map plus a one-line diagnosis of how each area fails you.

Day 5 — The gap that is not a skill

Record yourself answering one technical and one behavioural prompt, then count two things in the playback: how many seconds before your first clarifying question, and how many sentences you started without knowing where they ended.
Rewrite your three most-used stock phrases into shorter versions, and practise saying "I do not know, here is how I would find out" without softening it into a guess.
Deliver one answer again with a hard 90-second limit to force structure before detail.

Deliverable: Two recordings with a counted improvement in time-to-first-question.

Day 6 — Retest under day-one conditions

Sit the same 100-minute diagnostic structure with new prompts of comparable difficulty and score it on the identical rubric.
Compare block by block, and for any block that did not move, change the method rather than adding hours: a block stuck at 1 usually means the practice was too varied, not too short.
Write which single block you would still lose the offer on.

Deliverable: A second scored rubric placed next to the first, with one named remaining risk.

Day 7 — Full loop under interview conditions

Run a 60-minute mock covering the two blocks that moved least, with an interviewer instructed to interrupt and change direction.
Write your recovery script for the moment you go blank: restate the question, state your assumption, name the first thing you would check.
Reduce the week to the rule statements you wrote, each with its preconditions attached, then say every one of them out loud without reading it and cut any you cannot state in a single sentence, since a rule you have to reconstruct mid-answer will not survive being interrupted.

Deliverable: A one-page card holding the recovery script and only the rules you could state from memory.

Explaining a method to someone who will not follow the maths

Half of this section is about translation. Be ready to describe how you explained a result to someone who did not want the method, only the implication, and what you did when the simplified version started being repeated in a way that overstated it. Correcting your own simplification is a strong beat.

Why do you want to work at Boston Children's Hospital specifically?

Medium · behavioural and stakeholder questions

Approach

Quantify the outcome, including what you would not claim credit for.
Name the disagreement or constraint, and how you resolved it with evidence.
State the situation in two sentences and spend the rest on your reasoning.

Follow-up

What would you do differently if you ran that project again?
What did you decide not to do, and why?

How do you handle situations where your research findings contradict the expectations of senior leadership or clinical directors?

Medium · behavioural and stakeholder questions

Approach

Quantify the outcome, including what you would not claim credit for.
Pick a story where you drove the decision, not one where you observed it.
Name the disagreement or constraint, and how you resolved it with evidence.

Follow-up

How did you know the outcome was caused by your change?
What did you decide not to do, and why?

Explain an incomplete cost series to a non-technical executive

Medium · claims runout · uncertainty · executive communication

An executive opens a dashboard showing risk-adjusted allowed PMPM down 6 percent across the last three incurred months and asks whether the cost initiative is working. You know pharmacy adjudicates within days, professional claims within weeks, and inpatient facility claims over months, so those three months are both undercounted and mix-shifted toward cheap services. There is also a genuine movement of roughly 1.5 percent in the older, complete months. Deliverable: a two-minute spoken answer, the change you make to the chart, and what you commit to telling them and when.

Approach

The probe is whether you can be honest about uncertainty without sounding evasive. Executives read hedging as not knowing, so the answer has to end in a commitment.
Separate the two claims immediately. The 6 percent is an artefact of incomplete data, and there is a smaller real movement in the months that are complete. Delivering only the debunk leaves them holding nothing.
Explain the lag in their terms: the bills for the most expensive care arrive last, so an incomplete month always looks cheap and always looks like it is improving. Keep the phrase completion factor out of the first pass.
Fix the chart instead of explaining around it. Shade or omit the incomplete months, print the paid-through date on the axis, and overlay the same series as it looked at equivalent maturity a year earlier so the shape is comparable rather than merely lower.
Close with a date and a magnitude. Commit to a restated figure once runout matures, say roughly how far you expect the 6 percent to shrink, and name what you would need to see to call the initiative working.

Follow-up

They ask for your best guess today, knowing it is provisional. What do you say?
The restated number comes back at 1 percent. How do you handle having flagged the 6 percent at all?
How do you stop this dashboard producing the same conversation next quarter?